Literature DB >> 27760458

Chordomas and chondrosarcomas-The role of radiation therapy.

Karen De Amorim Bernstein1, Thomas DeLaney2.   

Abstract

Achieving negative surgical margins can be challenging for skull base and spinal/paraspinal sarcomas. Data shows that pre- or post-operative radiation therapy improves local control. Delivery of sufficient dose of radiation can be difficult because of the proximity to normal organs/tissues that are sensitive to radiation therapy and therefore dose-limiting. A comprehensive literature search was conducted using PubMed search engine. The scarcity of prospective, randomized data limits the ability to generate definitive treatment recommendations. J. Surg. Oncol. 2016;114:564-569.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  base of skull/spine; proton therapy; rare tumors

Mesh:

Year:  2016        PMID: 27760458     DOI: 10.1002/jso.24368

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  13 in total

Review 1.  Advances in the management of primary bone sarcomas of the skull base.

Authors:  Idara Edem; Franco DeMonte; Shaan M Raza
Journal:  J Neurooncol       Date:  2020-04-18       Impact factor: 4.130

Review 2.  Oncofertility in sarcoma patients.

Authors:  Diana M Lopategui; Raphael Yechieli; Ranjith Ramasamy
Journal:  Transl Androl Urol       Date:  2017-10

3.  Surgery and protontherapy in Grade I and II skull base chondrosarcoma: A comparative retrospective study.

Authors:  François Simon; Loïc Feuvret; Damien Bresson; Jean-Pierre Guichard; Sophie El Zein; Anne-Laure Bernat; Moujahed Labidi; Valentin Calugaru; Sébastien Froelich; Philippe Herman; Benjamin Verillaud
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

4.  Bystander effectors of chondrosarcoma cells irradiated at different LET impair proliferation of chondrocytes.

Authors:  Charlotte Lepleux; Aurélie Marie-Brasset; Mihaela Temelie; Marion Boulanger; Émilie Brotin; Mary B Goldring; Christophe Hirtz; Guillaume Varès; Tetsuo Nakajima; Yannick Saintigny; Diana Savu; François Chevalier
Journal:  J Cell Commun Signal       Date:  2019-03-22       Impact factor: 5.908

5.  Sensitization of chondrosarcoma cells with PARP inhibitor and high-LET radiation.

Authors:  Mathieu Césaire; Utpal Ghosh; Jean-Baptiste Austry; Etienne Muller; Francesco Paolo Cammarata; Marilyne Guillamin; Massimo Caruso; Laurent Castéra; Giada Petringa; Giuseppe Antonio Pablo Cirrone; François Chevalier
Journal:  J Bone Oncol       Date:  2019-06-20       Impact factor: 4.491

6.  Clear cell chondrosarcoma is an underestimated tumor: Report of 7 cases and meta-analysis of the literature.

Authors:  Alexander Klein; Felix Tauscher; Christof Birkenmaier; Andrea Baur-Melnyk; Thomas Knösel; Volkmar Jansson; Hans Roland Dürr
Journal:  J Bone Oncol       Date:  2019-10-31       Impact factor: 4.072

7.  Prognostic Factors and Treatment Options for Patients with High-Grade Chondrosarcoma.

Authors:  Zhongyang Gao; Teng Lu; Hui Song; Zhengchao Gao; Fenggang Ren; Pengrong Ouyang; Yibin Wang; Junjie Zhu; Songlin Zhou; Xijing He
Journal:  Med Sci Monit       Date:  2019-11-25

8.  Effects of a combined therapy of bortezomib and ionizing radiation on chondrosarcoma three-dimensional spheroid cultures.

Authors:  Birgit Lohberger; Dietmar Glaenzer; Nicole Eck; Bibiane Steinecker-Frohnwieser; Andreas Leithner; Beate Rinner; Sylvia Kerschbaum-Gruber; Dietmar Georg
Journal:  Oncol Lett       Date:  2021-03-30       Impact factor: 2.967

9.  Proton Therapy for Primary Bone Malignancy of the Pelvic and Lumbar Region - Data From the Prospective Registries ProReg and KiProReg.

Authors:  Rasin Worawongsakul; Theresa Steinmeier; Yi-Lan Lin; Sebastian Bauer; Jendrik Hardes; Stefanie Hecker-Nolting; Uta Dirksen; Beate Timmermann
Journal:  Front Oncol       Date:  2022-02-16       Impact factor: 6.244

10.  High LET Radiation Overcomes In Vitro Resistance to X-Rays of Chondrosarcoma Cell Lines.

Authors:  Francois Chevalier; Dounia Houria Hamdi; Charlotte Lepleux; Mihaela Temelie; Anaïs Nicol; Jean Baptiste Austry; Paul Lesueur; Guillaume Vares; Diana Savu; Tetsuo Nakajima; Yannick Saintigny
Journal:  Technol Cancer Res Treat       Date:  2019-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.